BE1027772B1 - COMPOSITION OF GINSENG TO IMPROVE SKIN CONDITION AND ITS USE FOR THE TREATMENT OF DERMATOLOGICAL DISEASES - Google Patents

COMPOSITION OF GINSENG TO IMPROVE SKIN CONDITION AND ITS USE FOR THE TREATMENT OF DERMATOLOGICAL DISEASES

Info

Publication number
BE1027772B1
BE1027772B1 BE20195810A BE201905810A BE1027772B1 BE 1027772 B1 BE1027772 B1 BE 1027772B1 BE 20195810 A BE20195810 A BE 20195810A BE 201905810 A BE201905810 A BE 201905810A BE 1027772 B1 BE1027772 B1 BE 1027772B1
Authority
BE
Belgium
Prior art keywords
composition
ginseng
treatment
skin condition
improve skin
Prior art date
Application number
BE20195810A
Other languages
French (fr)
Other versions
BE1027772A1 (en
Inventor
Sylvie Defrere
Pierre-Antoine Mariage
Original Assignee
Botalys Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Botalys Sa filed Critical Botalys Sa
Priority to BE20195810A priority Critical patent/BE1027772B1/en
Priority to PCT/EP2020/074649 priority patent/WO2021043927A1/en
Priority to JP2022513665A priority patent/JP2022553120A/en
Priority to AU2020342706A priority patent/AU2020342706A1/en
Priority to EP20771997.2A priority patent/EP4025231A1/en
Priority to US17/753,391 priority patent/US20220288147A1/en
Publication of BE1027772A1 publication Critical patent/BE1027772A1/en
Application granted granted Critical
Publication of BE1027772B1 publication Critical patent/BE1027772B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur une composition, un kit et sa préparation pour améliorer l'état de la peau d'un sujet. L'invention concerne également la composition destinée à être utilisée comme substance médicale ou thérapeutique. La composition comprend un ginsénoside rare, un ginsan et un gintonin. De préférence, le rapport entre le ginsan et la gintonine est d'au moins 500:1 et d'au plus 1:100. De préférence, le rapport des ginsénosides rares au ginsan et à la gintonine est d'au moins 250:1 et d'au plus 1:40.Disclosed is a composition, kit and preparation for improving the condition of the skin of a subject. The invention also relates to the composition for use as a medical or therapeutic substance. The composition includes a rare ginsenoside, a ginsan and a gintonin. Preferably, the ratio of ginsan to gintonine is at least 500: 1 and at most 1: 100. Preferably, the ratio of rare ginsenosides to ginsan and gintonine is at least 250: 1 and at most 1:40.

BE20195810A 2019-09-03 2019-11-21 COMPOSITION OF GINSENG TO IMPROVE SKIN CONDITION AND ITS USE FOR THE TREATMENT OF DERMATOLOGICAL DISEASES BE1027772B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BE20195810A BE1027772B1 (en) 2019-11-21 2019-11-21 COMPOSITION OF GINSENG TO IMPROVE SKIN CONDITION AND ITS USE FOR THE TREATMENT OF DERMATOLOGICAL DISEASES
PCT/EP2020/074649 WO2021043927A1 (en) 2019-09-03 2020-09-03 Ginseng composition and use thereof as a medicament
JP2022513665A JP2022553120A (en) 2019-09-03 2020-09-03 Carrot composition and its use as a medicament
AU2020342706A AU2020342706A1 (en) 2019-09-03 2020-09-03 Ginseng composition and use thereof as a medicament
EP20771997.2A EP4025231A1 (en) 2019-09-03 2020-09-03 Ginseng composition and use thereof as a medicament
US17/753,391 US20220288147A1 (en) 2019-09-03 2020-09-03 Ginseng composition and use thereof as a medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE20195810A BE1027772B1 (en) 2019-11-21 2019-11-21 COMPOSITION OF GINSENG TO IMPROVE SKIN CONDITION AND ITS USE FOR THE TREATMENT OF DERMATOLOGICAL DISEASES

Publications (2)

Publication Number Publication Date
BE1027772A1 BE1027772A1 (en) 2021-06-15
BE1027772B1 true BE1027772B1 (en) 2021-06-21

Family

ID=69571743

Family Applications (1)

Application Number Title Priority Date Filing Date
BE20195810A BE1027772B1 (en) 2019-09-03 2019-11-21 COMPOSITION OF GINSENG TO IMPROVE SKIN CONDITION AND ITS USE FOR THE TREATMENT OF DERMATOLOGICAL DISEASES

Country Status (1)

Country Link
BE (1) BE1027772B1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663160A (en) * 1992-09-17 1997-09-02 Lvmh Recherche Cosmetic or dermatological composition containing at least one saponin of the ginsenoside type, and its applications, especially for treating the hair
FR2767057A1 (en) * 1997-08-08 1999-02-12 Lvmh Rech USE OF GINSENOSIDE RB1 AS AN AGENT FOR STIMULATING THE SYNTHESIS OF ELASTINE
WO2013176512A1 (en) * 2012-05-25 2013-11-28 Korea Institute Of Science And Technology Panax spp. plant extract with increased content ratio of ginsenoside rg3, rg5, and rk1 produced by microwave irradiation, a method of preparing the panax spp. plant extract, and a composition including the panax spp. plant extract

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574806A (en) 1976-06-03 1980-09-10 Inverni Della Beffa Spa Production of purified ginseng extracts and pharmaceutical compositions containing the extracts
US4966893A (en) 1989-01-13 1990-10-30 Pang Peter K T Method for treatment of senile dementia
JPH04316448A (en) 1991-04-12 1992-11-06 Iwatani Internatl Corp Production of carrot fine powder
US6083932A (en) 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
CA2301860C (en) 1997-08-28 2009-05-26 Cv Technologies Inc. Chemical and pharmacological standardization of herbal extracts
CN1630528A (en) 1999-08-30 2005-06-22 独立行政法人科学技术振兴机构 Brain cell or nerve cell protecting agents comprising ginseng
JP2002249498A (en) 2001-02-21 2002-09-06 Japan Science & Technology Corp Antiapoptosis preparation or regeneration accelerating reagent containing ginesenosides derivatives
JP2002255826A (en) 2001-02-27 2002-09-11 Japan Science & Technology Corp Corneal tissue regeneration-stimulating agent
JP2003070496A (en) 2001-09-03 2003-03-11 Shin Sangyo Gijutsu Kenkyusho:Kk Method for evaluating pharmaceutically active saponin and pharmaceutically active saponin
JP2004077456A (en) 2002-06-18 2004-03-11 Masahiro Sakanaka Method for screening ginsenoside rb1-like substance
KR100521505B1 (en) 2003-05-14 2005-10-12 주식회사 바이오사포젠 UV-pretective constituents of gisenosides
JP2006028150A (en) 2004-07-20 2006-02-02 Fumiyuki Terada Skin elasticity activation cosmetic
KR100973202B1 (en) 2009-11-17 2010-07-30 건국대학교 산학협력단 Novel glycolipoprotein from ginseng and manufacturing method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663160A (en) * 1992-09-17 1997-09-02 Lvmh Recherche Cosmetic or dermatological composition containing at least one saponin of the ginsenoside type, and its applications, especially for treating the hair
FR2767057A1 (en) * 1997-08-08 1999-02-12 Lvmh Rech USE OF GINSENOSIDE RB1 AS AN AGENT FOR STIMULATING THE SYNTHESIS OF ELASTINE
WO2013176512A1 (en) * 2012-05-25 2013-11-28 Korea Institute Of Science And Technology Panax spp. plant extract with increased content ratio of ginsenoside rg3, rg5, and rk1 produced by microwave irradiation, a method of preparing the panax spp. plant extract, and a composition including the panax spp. plant extract

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Ginseng HRG80 in Stress and Fatigue - Full Text View - ClinicalTrials.gov", 13 May 2019 (2019-05-13), XP055692252, Retrieved from the Internet <URL:https://clinicaltrials.gov/ct2/show/NCT03947554> [retrieved on 20200506] *
HWANG JI EUN ET AL: "Comparative study on anti-oxidative and anti-inflammatory properties of hydroponic ginseng and soil-cultured ginseng", FOOD SCIENCE AND BIOTECHNOLOGY, THE KOREA SOC. OF FOOD SCIENCE AND TECHNOLOGY, HEIDELBERG, vol. 28, no. 1, 30 August 2018 (2018-08-30), pages 215 - 224, XP036980989, ISSN: 1226-7708, [retrieved on 20180830], DOI: 10.1007/S10068-018-0450-X *
PIERRE-ANTOINE MARIAGE ET AL: "Efficacy of Panax ginseng Meyer Herbal Preparation HRG80 in Preventing and Mitigating Stress-Induced Failure of Cognitive Functions in Healthy Subjects: A Pilot, Randomized, Double-Blind, Placebo-Controlled Crossover Trial", PHARMACEUTICALS, vol. 13, no. 4, 29 March 2020 (2020-03-29), CH, pages 57, XP055691690, ISSN: 1424-8247, DOI: 10.3390/ph13040057 *
PIERRE-ANTOINE MARIAGE: "Ginseng HRG80 : un nouvel ingrédient naturel à l'efficacité renforcée", 13 November 2018 (2018-11-13), XP055692164, Retrieved from the Internet <URL:https://www.mynaturalorigins.com/fr/blog/ginseng-hrg80-un-nouvel-ingredient-naturel-a-l-efficacite-renforcee> [retrieved on 20200506] *
PIERRE-ANTOINE MARIAGE: "Ginseng HRG80 : un nouvel ingrédient naturel à l'efficacité renforcée", 22 November 2018 (2018-11-22), XP055692168, Retrieved from the Internet <URL:https://www.mynaturalorigins.com/fr/blog/ginseng-hrg80-un-nouvel-ingredient-naturel-a-l-efficacite-renforcee> [retrieved on 20200506] *
PIERRE-ANTOINE MARIAGE: "Pourquoi opter pour le ginseng HRG80 dans vos produits nutraceutiques ?", 20 November 2018 (2018-11-20), XP055692170, Retrieved from the Internet <URL:https://www.mynaturalorigins.com/fr/blog/pourquoi-opter-pour-le-ginseng-hrg80-dans-vos-produits-nutraceutiques> [retrieved on 20200506] *

Also Published As

Publication number Publication date
BE1027772A1 (en) 2021-06-15

Similar Documents

Publication Publication Date Title
Vieira et al. Oral piercings: immediate and late complications
Santana et al. Clinical evaluation of single‐stage advanced versus rotated flaps in the treatment of gingival recessions
HUP0400548A2 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
ATE506059T1 (en) THERAPY TO TREAT OVERACTIVE BLADDER
DE04702967T1 (en) TREATMENT OF BENIGNER PROSTATE HYPERPLASIA
CA2629364A1 (en) Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
FR3047177B1 (en) COSMETIC, DERMATOLOGICAL COMPOSITIONS COMPRISING AN EXTRACT OF VITEX NEGUNDO ENRICHED IN POLYPHENOLS
Power-Smith Beneficial sexual side-effects from fluoxetine
TW200511996A (en) The use of steroids to treat persons suffering from ocular disorders
D'Agostino et al. Efficacy and tolerability of lovastatin in hypercholesterolemia in patients with systemic hypertension
BE1027772B1 (en) COMPOSITION OF GINSENG TO IMPROVE SKIN CONDITION AND ITS USE FOR THE TREATMENT OF DERMATOLOGICAL DISEASES
Razikova The condition of tissues in the oral cavity of patients with complications of arterial hypertension COVID-19
White et al. Effects of naproxcinod on blood pressure in patients with osteoarthritis
Engelsman et al. Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an EORTC study.
Hansson Antihypertensive treatment: does the J-curve exist?
Dadkar et al. Double blind comparative trial of Abana and methyldopa for monotherapy of hypertension in Indian patients
De Wilde et al. A double‐blind randomized placebo‐controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression
RU2577240C1 (en) Method of treatment of traumatic injuries of oral mucosa in the process of orthodontic treatment
Gadzhula et al. Efficiency of treatment of inflammatory periodontal diseases in pregnant women
RU2519100C1 (en) Method of treating hypertrophic gingivitis
WO2020071665A3 (en) Composition for extending telomere of cell and preparation method therefor
Bardet et al. Clinical effects of root instrumentation using conventional steel or non‐tooth substance removing plastic curettes during supportive periodontal therapy (SPT)
Tysnes Treatment of sialorrhea in amyotrophic lateral sclerosis
Abhirami et al. Antimicrobial and Analgesic Effect of Dhoopana with Sriveshtakadi Choorna in Non-Healing Ulcer-A Case Study
SU1789214A1 (en) Method of paradontitis treatment

Legal Events

Date Code Title Description
FG Patent granted

Effective date: 20210621